Altered acetylcholine release in the hippocampus of dystrophin-deficient mice

Neuroscience

Volumn 269, Issue , 2014, Pages 173-183

  Parames, S F ^a   Coletta Yudice, E D ^a,c   Nogueira, F M ^a   Nering de Sousa, M B ^a   Hayashi, M A ^a   Lima Landman, M T R ^a   Lapa, A J ^a,b   Souccar, C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Amazon Biotechnology Center   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Dystrophin; Hippocampus; Mdx mouse; Nicotinic acetylcholine receptor; Vesicular ACh transporter

Indexed keywords

ACETYLCHOLINE; DYSTROPHIN; POTASSIUM ION; VESICULAR ACETYLCHOLINE TRANSPORTER; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BETA2; NICOTINIC RECEPTOR BLOCKING AGENT; POTASSIUM CHLORIDE; SLC18A3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; DEPOLARIZATION; EVOKED CORTICAL RESPONSE; HIPPOCAMPUS; MALE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; SYNAPTOSOME; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; DEFICIENCY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ACETYLCHOLINE; ANIMALS; BLOTTING, WESTERN; CEREBELLUM; CEREBRAL CORTEX; DYSTROPHIN; HIPPOCAMPUS; MALE; MICE, INBRED C57BL; MICE, INBRED MDX; NICOTINIC ANTAGONISTS; POTASSIUM CHLORIDE; RECEPTORS, NICOTINIC; SYNAPTOSOMES; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 84898784597     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.03.050     Document Type: Article

References (75)

1. Albuquerque E.X., Pereira E.F., Alkondon M., Rogers S.W. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 2009, 89:73-120.
2. 3H]methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain. J Neurochem 1988, 51:292-299.
3. Batchelor C.L., Winder S.J. Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy. Trends Cell Biol 2006, 16:198-205.
4. Blake D.J., Weir A., Newey S.E., Davies K.E. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002, 82:291-329.
5. Bogen I.L., Boulland J.L., Mariussen E., Wright M.S., Fonnum F., Kao H.T., Walaas S.I. Absence of synapsin I and II is accompanied by decreases in vesicular transport of specific neurotransmitters. J Neurochem 2006, 96:1458-1466.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
7. Comim C.M., Moraz T., Abreu I., Fraga D.B., Ghedim F.V., Mildner N., Tuon L., Vainzof M., Zugno A.I., Quevedo J. Reduction of acethylcolinesterase activity in the brain of mdx mice. Neuromuscul Disord 2011, 21:359-362.
8. Cyrulnik S.E., Fee R.J., Batchelder A., Kiefel J., Goldstein E., Hinton V.J. Cognitive and adaptive deficits in young children with Duchenne muscular dystrophy (DMD). J Int Neuropsychol Soc 2008, 14:853-861.
9. Dajas-Bailador F., Wonnacott S. Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 2004, 25:317-324.
10. D'Angelo M.G., Bresolin N. Cognitive impairment in neuromuscular disorders. Muscle Nerve 2006, 34:16-33.
11. Drever B.D., Riedel G., Platt B. The cholinergic system and hippocampal plasticity. Behav Brain Res 2011, 221:505-514.
12. Durrant A.R., Tamayev L., Anglister L. Serum cholinesterases are differentially regulated in normal and dystrophin-deficient mutant mice. Front Mol Neurosci 2012, 5:73. 10.3389/fnmol.2012.00073.
13. Edwards R.H. The neurotransmitter cycle and quantal size. Neuron 2007, 55:835-858.
14. Engelman H.S., MacDermott A.B. Presynaptic ionotropic receptors and control of transmitter release. Nat Rev Neurosci 2004, 5:135-145.
15. Ervasti J.M. Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta 2007, 1772:108-117.
16. Fradkin L.G., Baines R.A., van der Plas M.C., Noordermeer J.N. The dystrophin Dp186 isoform regulates neurotransmitter release at a central synapse in Drosophila. J Neurosci 2008, 28:5105-5114.
17. 2+ permeability of nicotinic acetylcholine receptors. Cell Calcium 2004, 35:1-8.
18. Gailly P. New aspects of calcium signaling in skeletal muscle cells: implications in Duchenne muscular dystrophy. Biochim Biophys Acta 2002, 1600:38-44.
19. Garcia-Sanz A., Badia A., Clos M.V. Superfusion of synaptosomes to study presynaptic mechanisms involved in neurotransmitter release from rat brain. Brain Res Brain Res Protoc 2001, 7:94-102.
20. Ghedini P.C., Avellar M.C., De Lima T.C., Lima-Landman M.T., Lapa A.J., Souccar C. Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice. Brain Res 2012, 1483:96-104.
21. Ghedini P.C., Viel T.A., Honda L., Avellar M.C., Godinho R.O., Lima-Landman M.T., Lapa A.J., Souccar C. Increased expression of acetylcholine receptors in the diaphragm muscle of mdx mice. Muscle Nerve 2008, 38:1585-1594.
22. Gotti C., Zoli M., Clementi F. Brain nicotinic acetylcholine receptors: native subtypes and their relevance. Trends Pharmacol Sci 2006, 27:482-491.
23. Graciotti L., Minelli A., Minciacchi D., Procopio A., Fulgenzi G. GABAergic miniature spontaneous activity is increased in the CA1 hippocampal region of dystrophic mdx mice. Neuromuscul Disord 2008, 18:220-226.
24. Grady R.M., Zhou H., Cunningham J.M., Henry M.D., Campbell K.P., Sanes J.R. Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin-glycoprotein complex. Neuron 2000, 25:279-293.
25. Grady S.R., Meinerz N.M., Cao J., Reynolds A.M., Picciotto M.R., Changeux J.P., McIntosh J.M., Marks M.J., Collins A.C. Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. J Neurochem 2001, 76:258-268.
26. Gray E.G., Whittaker V.P. The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat 1962, 96:79-88.
27. Hendriksen J.G., Vles J.S. Neuropsychiatric disorders in males with Duchenne muscular dystrophy: frequency rate of attention-deficit hyperactivity disorder (ADHD), autism spectrum disorder, and obsessive-compulsive disorder. J Child Neurol 2008, 23:477-481.
28. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928.
29. Hopf F.W., Steinhardt R.A. Regulation of intracellular free calcium in normal and dystrophic mouse cerebellar neurons. Brain Res 1992, 578:49-54.
30. *) nAChRs: underlying cholinergic mechanisms. Neuropsychopharmacology 2010, 35:1391-1401.
31. Huh K.H., Fuhrer C. Clustering of nicotinic acetylcholine receptors: from the neuromuscular junction to interneuronal synapses. Mol Neurobiol 2002, 25:79-112.
32. Hurst R., Rollema H., Bertrand D. Nicotinic acetylcholine receptors: from basic science to therapeutics. Pharmacol Ther 2013, 137:22-54.
33. Karadsheh M.S., Shah M.S., Tang X., Macdonald R.L., Stitzel J.A. Functional characterization of mouse alpha4beta2 nicotinic acetylcholine receptors stably expressed in HEK293T cells. J Neurochem 2004, 91:1138-1150.
34. Kenney J.W., Gould T.J. Modulation of hippocampus-dependent learning and synaptic plasticity by nicotine. Mol Neurobiol 2008, 38:101-121.
35. Kim T.W., Wu K., Xu J.L., Black I.B. Detection of dystrophin in the postsynaptic density of rat brain and deficiency in a mouse model of Duchenne muscular dystrophy. Proc Natl Acad Sci USA 1992, 89:11642-11644.
36. A receptors in mice lacking dystrophin (mdx mice). Eur J Neurosci 1999, 11:4457-4462.
37. Kueh S.L., Head S.I., Morley J.W. GABA(A) receptor expression and inhibitory post-synaptic currents in cerebellar Purkinje cells in dystrophin-deficient mdx mice. Clin Exp Pharmacol Physiol 2008, 35:207-210.
38. Lapidos K.A., Kakkar R., McNally E.M. The dystrophin glycoprotein complex: signaling strength and integrity for the sarcolemma. Circ Res 2004, 94:1023-1031.
39. Levin E.D., McClernon F.J., Rezvani A.H. Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 2006, 184:523-539.
40. Lidov H.G., Byers T.J., Kunkel L.M. The distribution of dystrophin in the murine central nervous system: an immunocytochemical study. Neuroscience 1993, 54:167-187.
41. Lidov H.G., Byers T.J., Watkins S.C., Kunkel L.M. Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature 1990, 348:725-728.
42. MacDermott A.B., Role L.W., Siegelbaum S.A. Presynaptic ionotropic receptors and the control of transmitter release. Annu Rev Neurosci 1999, 22:443-485.
43. Mansvelder H.D., Mertz M., Role L.W. Nicotinic modulation of synaptic transmission and plasticity in cortico-limbic circuits. Semin Cell Dev Biol 2009, 20:432-440.
44. Marchi M., Raiteri M. Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of "impaired" cholinergic presynaptic function. J Neurochem 1996, 67:1974-1981.
45. 2+ ions in their function and desensitization. Neurochem Int 1999, 34:319-328.
46. Marks M.J., Laverty D.S., Whiteaker P., Salminen O., Grady S.R., McIntosh J.M., Collins A.C. John Daly's compound, epibatidine, facilitates identification of nicotinic receptor subtypes. J Mol Neurosci 2010, 40:96-104.
47. Marks M.J., Whiteaker P., Calcaterra J., Stitzel J.A., Bullock A.E., Grady S.R., Picciotto M.R., Changeux J.P., Collins A.C. Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit. J Pharmacol Exp Ther 1999, 289:1090-1103.
48. Mehler M.F. Brain dystrophin, neurogenetics and mental retardation. Brain Res Brain Res Rev 2000, 32:277-307.
49. Millar N.S., Gotti C. Diversity of vertebrate nicotinic acetylcholine receptors. Neuropharmacology 2009, 56:237-246.
50. Miranda R., Nudel U., Laroche S., Vaillend C. Altered presynaptic ultrastructure in excitatory hippocampal synapses of mice lacking dystrophins Dp427 or Dp71. Neurobiol Dis 2011, 43:134-141.
51. Nagel A., Lehmann-Horn F., Engel A.G. Neuromuscular transmission in the mdx mouse. Muscle Nerve 1990, 13:742-749.
52. Nagy P.M., Aubert I. Overexpression of the vesicular acetylcholine transporter increased acetylcholine release in the hippocampus. Neuroscience 2012, 218:1-11.
53. Perronnet C., Vaillend C. Dystrophins, utrophins, and associated scaffolding complexes: role in mammalian brain and implications for therapeutic strategies. J Biomed Biotechnol 2010, 2010:849426. 10.1155/2010/849426.
54. Picciotto M.R., Higley M.J., Mineur Y.S. Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron 2012, 76:116-129.
55. Pilgram G.S., Potikanond S., Baines R.A., Fradkin L.G., Noordermeer J.N. The roles of the dystrophin-associated glycoprotein complex at the synapse. Mol Neurobiol 2010, 41:1-21.
56. Prado V.F., Martins-Silva C., de Castro B.M., Lima R.F., Barros D.M., Amaral E., Ramsey A.J., Sotnikova T.D., Ramirez M.R., Kim H.G., Rossato J.I., Koenen J., Quan H., Cota V.R., Moraes M.F., Gomez M.V., Guatimosim C., Wetsel W.C., Kushmerick C., Pereira G.S., Gainetdinov R.R., Izquierdo I., Caron M.G., Prado M.A. Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 2006, 51:601-612.
57. Rae C., Griffin J.L., Blair D.H., Bothwell J.H., Bubb W.A., Maitland A., Head S. Abnormalities in brain biochemistry associated with lack of dystrophin: studies of the mdx mouse. Neuromuscul Disord 2002, 12:121-129.
58. Sacco K.A., Bannon K.L., George T.P. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. J Psychopharmacol 2004, 18:457-474.
59. Sakamoto T., Arima T., Ishizaki M., Kawano R., Koide T., Uchida Y., Yamashita S., Kimura E., Hirano T., Maeda Y., Uchino M. Regions downstream from the WW domain of dystrophin are important for binding to postsynaptic densities in the brain. Neuromuscul Disord 2008, 18:382-388.
60. Sarter M., Bruno J.P., Parikh V. Abnormal neurotransmitter release underlying behavioral and cognitive disorders: toward concepts of dynamic and function-specific dysregulation. Neuropsychopharmacology 2007, 32:1452-1461.
61. Schicker K.W., Dorostkar M.M., Boehm S. Modulation of transmitter release via presynaptic ligand-gated ion channels. Curr Mol Pharmacol 2008, 1:106-129.
62. Sealock R., Butler M.H., Kramarcy N.R., Gao K.X., Murnane A.A., Douville K., Froehner S.C. Localization of dystrophin relative to acetylcholine receptor domains in electric tissue and adult and cultured skeletal muscle. J Cell Biol 1991, 113:1133-1144.
63. Sekiguchi M., Zushida K., Yoshida M., Maekawa M., Kamichi S., Yoshida M., Sahara Y., Yuasa S., Takeda S., Wada K. A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain 2009, 132:124-135.
64. Snow W.M., Anderson J.E., Jakobson L.S. Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review. Neurosci Biobehav Rev 2013, 37:743-752.
65. Südhof T.C. Calcium control of neurotransmitter release. Cold Spring Harb Perspect Biol 2012, 4:a011353. 10.1101/cshperspect.a011353.
66. Tanaka Y., Hasegawa A., Ando S. Impaired synaptic functions with aging as characterized by decreased calcium influx and acetylcholine release. J Neurosci Res 1996, 43:63-70.
67. van der Plas M.C., Pilgram G.S., Plomp J.J., de Jong A., Fradkin L.G., Noordermeer J.N. Dystrophin is required for appropriate retrograde control of neurotransmitter release at the Drosophila neuromuscular junction. J Neurosci 2006, 26:333-344.
68. Vaillend C., Billard J.M., Laroche S. Impaired long-term spatial and recognition memory and enhanced CA1 hippocampal LTP in the dystrophin-deficient Dmd (mdx) mouse. Neurobiol Dis 2004, 17:10-20.
69. Waite A., Tinsley C.L., Locke M., Blake D.J. The neurobiology of the dystrophin-associated glycoprotein complex. Ann Med 2009, 41:344-359.
70. Wallis T., Bubb W.A., McQuillan J.A., Balcar V.J., Rae C. For want of a nail. Ramifications of a single gene deletion, dystrophin, in the brain of the mouse. Front Biosci 2004, 9:74-84.
71. 3H]-methyllycaconitine in the mouse brain. Eur J Neurosci 1999, 11:2689-2696.
72. Wilkie G.I., Hutson P., Sullivan J.P., Wonnacott S. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochem Res 1996, 21:1141-1148.
73. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci 1997, 20:92-98.
74. Yoshihara Y., Onodera H., Iinuma K., Itoyama Y. Abnormal kainic acid receptor density and reduced seizure susceptibility in dystrophin-deficient mdx mice. Neuroscience 2003, 117:391-395.
75. Zappettini S., Grilli M., Salamone A., Fedele E., Marchi M. Pre-synaptic nicotinic receptors evoke endogenous glutamate and aspartate release from hippocampal synaptosomes by way of distinct coupling mechanisms. Br J Pharmacol 2010, 161:1161-1171.